lapachol has been researched along with Leishmaniasis, Cutaneous in 2 studies
lapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araújo, IAC | 1 |
de Paula, RC | 1 |
Alves, CL | 1 |
Faria, KF | 1 |
Oliveira, MM | 1 |
Mendes, GG | 1 |
Dias, EMFA | 1 |
Ribeiro, RR | 1 |
Oliveira, AB | 1 |
Silva, SMD | 1 |
Teixeira, MJ | 1 |
de Almeida, YM | 1 |
Viana, JR | 1 |
Holanda Filha, JG | 1 |
Rodrigues, TP | 1 |
Prata, JR | 1 |
Coêlho, IC | 1 |
Rao, VS | 1 |
Pompeu, MM | 1 |
2 other studies available for lapachol and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Flow Cytometry; Hep G | 2019 |
In vitro and in vivo Leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (lapachol).
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Female | 2001 |